These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20226737)

  • 1. Lipoxins: regulators of resolution.
    Ryan A; Godson C
    Curr Opin Pharmacol; 2010 Apr; 10(2):166-72. PubMed ID: 20226737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):141-62. PubMed ID: 16005201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoxins: update and impact of endogenous pro-resolution lipid mediators.
    O'Meara SJ; Rodgers K; Godson C
    Rev Physiol Biochem Pharmacol; 2008; 160():47-70. PubMed ID: 18481030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins.
    Petasis NA; Akritopoulou-Zanze I; Fokin VV; Bernasconi G; Keledjian R; Yang R; Uddin J; Nagulapalli KC; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):301-21. PubMed ID: 16098719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
    Serhan CN; Chiang N
    Rheum Dis Clin North Am; 2004 Feb; 30(1):69-95. PubMed ID: 15061569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoxins--new view on old mediators carrying potent anti-inflammatory action].
    Jarmakowska K; Kuna P
    Pol Merkur Lekarski; 2005 May; 18(107):491-5. PubMed ID: 16161940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel omega -- 3-derived local mediators in anti-inflammation and resolution.
    Serhan CN
    Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver: the formation and actions of aspirin-triggered lipoxins.
    Clària J; Planagumà A
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):277-82. PubMed ID: 16006110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis.
    O'Meara YM; Brady HR
    Kidney Int Suppl; 1997 Mar; 58():S56-61. PubMed ID: 9067945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoxins: endogenous regulators of inflammation.
    McMahon B; Godson C
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F189-201. PubMed ID: 14707005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoxins and synthetic lipoxin mimetics: Therapeutic potential in renal diseases.
    Andrews D; Godson C
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158940. PubMed ID: 33839296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
    Romano M; Maddox JF; Serhan CN
    J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion.
    Nigam S; Fiore S; Luscinskas FW; Serhan CN
    J Cell Physiol; 1990 Jun; 143(3):512-23. PubMed ID: 2162850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin analogs: novel anti-inflammatory mediators.
    Gewirtz A
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1112-5. PubMed ID: 16312131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
    O'Sullivan TP; Vallin KS; Shah ST; Fakhry J; Maderna P; Scannell M; Sampaio AL; Perretti M; Godson C; Guiry PJ
    J Med Chem; 2007 Nov; 50(24):5894-902. PubMed ID: 17960922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation?
    Bonnans C; Chanez P; Chavis C
    Allergy; 2004 Oct; 59(10):1027-41. PubMed ID: 15355460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
    Papayianni A; Serhan CN; Brady HR
    J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils.
    Vachier I; Chanez P; Bonnans C; Godard P; Bousquet J; Chavis C
    Biochem Biophys Res Commun; 2002 Jan; 290(1):219-24. PubMed ID: 11779156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxins: resolutionary road.
    Maderna P; Godson C
    Br J Pharmacol; 2009 Oct; 158(4):947-59. PubMed ID: 19785661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
    Chiang N; Arita M; Serhan CN
    Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.